true

BD Named Top 3 Diversity Leader in Europe by Financial Times

European Diversity Leader Award
Publish date: 16-12-2024

BD, a leading global medical technology company, today announced that it has been named a top diversity leader in Europe, securing third place in the prestigious Financial Times Diversity Leader Award.

“This accolade underscores our commitment to fostering an inclusive workplace where our people feel connected, engaged, and empowered to realize their full potential and thrive,” said Jean-Thierry Molle, Vice President Human Resources for BD EMEA. “We take immense pride in our progress and remain steadfast in our dedication to supporting a workforce that best serves communities and customers, which helps us to be more innovative for our customers and patients.”

The evaluation process involved a comprehensive survey of over 100,000 employees from across Europe, alongside multiple indicators. 70% of a company’s final score is derived from employee surveys, with the indicators contributing the remaining 30%. To view the full list of recipients and methodology, visit FT-Statista.

This award demonstrates progress against BD’s 2030+ corporate sustainability goals and commitments, including programs to maintain a healthy and thriving workforce that cultivates our culture of inclusion, safety and well-being, and contributes to advancing equitable health around the world. To learn more, read BD’s Fiscal Year 2023 Corporate Sustainability Report and visit BD.com to understand how inclusion, diversity and equity are integral parts of our culture. For a full list of awards, visit news.bd.com/Award-news.

About BD

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 75,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo.

true

Contact

Troy Kirkpatrick

858 617 2361

Email Troy

true
true